Prostate Flashcards

1
Q

Is screening for prostate cancer recommended ?

A

NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BPH risk factors

A

Age, obesity, diabetes, family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BPH complications

A

UTI, bladder stone, urinary retention, hydronephrosis, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DDx Urinary Retention (8)

A

BPH
Prostate CA
Urethral stricture
Urethral diverticulum (women)
Medication
Infection
Trauma
Neurological (Spinal cord injury)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Voiding sx
predominant in bladder outlet obstruction (BOO) secondary to BPH (4)

A

Hesitancy, Weak Stream, Intermittence, Straining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

storage sx (4)

r/o overactive bladder (OAB)

A

Urgency, Frequency, Urgency Incontinence, Nocturia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

nocturnal polyuria

how many pees to be significant

A

2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

investigations for Lower Urinary Tract Symptoms (LUTS)

A

Urinalysis +/- culture (r/o infection)
PSA

PVR if considering anticholinergics (eg. storage symptoms suggesting OAB)
aka post voiding residual = bladder scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Urinary retention - medication that can precipitate

A

decongestants
antihistamines
antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Decongestants (e.g., Pseudoephedrine, Phenylephrine) mechanism of action in urinary retention

A

Stimulate alpha receptors, tightening the bladder neck and urethral sphincter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antihistamines (e.g., Diphenhydramine, Loratadine, Cetirizine) mechanism of action in urinary retention

A

Anticholinergic effects reduce bladder muscle contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline, Nortriptyline) mechanism of action in urinary retention

A

Strong anticholinergic effects slow bladder contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selective Serotonin Reuptake Inhibitors (SSRIs) mechanism of action in urinary sx

A

Affect serotonin regulation, which influences bladder control.

✅ Increased urinary frequency or urgency
✅ Possible incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rx for BPH

A
  • Tamsulosin (Flomax) CR 0.4mg PO daily = alpha blocker

For larger prostates combination therapy more effective with
5-alpha reductase inhibitors (onhibit conversion of testosterone to DHT, onset 4-6 months)

  • Dutasteride (Avodart) 0.5mg PO daily
  • or Finasteride (Proscar)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when to stop combination therapy

A

After 6-9 months of combination therapy, consider stopping alpha blocker

5-alpha reductase inhibitors take 4-6 months to work fully

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anticholinergics when to prescribe

A

if storage sx :

overactive bladder (OAB)
Urgency, Frequency, Urgency Incontinence, Nocturia

17
Q

ex of anticholinergics

A

Tolterodine, Oxybutynin, Mirabegron)

18
Q

bacteril prostatitis tx

A

Septra DS 1 tab q12h x 6 weeks (or 12 weeks for chronic)

or Ciprofloxacin 500mg PO q12h x 6 weeks (for both acute and chronic)

19
Q

Prostatie non infx ddx

A

Target UPOINTS

Urinary (storage/voiding symptoms)
Tamsulosin 0.4mg PO daily (a-blocker), antimuscarinics

Psychosocial
CBT, counselling, antidepressants, anxiolytics

Organ specific (prostate tenderness, hematospermia)
Quercetin, pollen extract

Infection (positive cultures in prostate sample, previous UTI)
Fluoroquinolone x 6 weeks

Neurologic / Pain
Acetaminophen, NSAIDs
Gabapentinoids, TCA, acupuncture

Tenderness (pelvic floor spasm, trigger points)
Physiotherapy (pelvic floor relaxation), exercise, heat therapy

Sexual dysfunction
PDE-5 inhibitors